About MPS Pharmaa Limited
MPS Pharmaa Limited is a publicly listed company based in Delhi (India) founded in 1997. It operates as a bus tours and water sports to Key West are provided. It operates on a Reseller / Distribution model. Its chief executive is Rajeev Awasthi. Its Indian entity Mps Pharmaa Limited reported revenue of ₹4.8 Lakh. MPS Pharmaa Limited offers products and services including Anti-Allergic Medicines, Anti-Inflammatory Medicines, and Antibiotics. Its focus areas include Pharmaceuticals and Generic Drugs.
Company details
MPS Pharmaa Limited, formerly known as Advik Laboratories Limited, is involved in the manufacturing and exporting of a wide range of pharmaceutical medicines. Products include anti-allergic capsules and tablets, anti-inflammatory drugs, antihypertensives, analgesics, antipyretics, and antibiotics. The company operates with WHO and GMP certifications, aiming for USFDA quality standards. It serves both Indian and global markets, maintaining leadership in product quality, competitive pricing, and customer service. The business is supported by a team of qualified professionals dedicated to producing high-quality medicines for various therapeutic needs.
- Headquarters Delhi, India
- Stage Public
- SectorsHealthcare
- Phone•••• ••••
- Website advikindia.com
- Social LinkedIn
- Legal Name Mps Pharmaa Limited
- Date of Incorporation 09 Sep, 1994
- Jurisdiction Gurgaon, Haryana, India
- Annual Revenue₹4.8 Lakh
FY 2025 · -49% YoY
- Net Loss-₹89.8 Lakh
FY 2025 · -1882% margin
- EBITDA-₹71.7 Lakh
FY 2025 · -1502% margin
Associated legal entities of MPS Pharmaa Limited
MPS Pharmaa Limited operates through Mps Pharmaa Limited, a listed company (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Mps Pharmaa Limited Listed CIN L74899HR1994PLC038300 | Active | 09 Sep 1994 | Gurgaon, Haryana | ₹0.0 Cr | 13 | 6 | View details |
Products & Services of MPS Pharmaa Limited
MPS Pharmaa Limited offers a comprehensive portfolio of products and services, including Anti-Allergic Medicines, Anti-Inflammatory Medicines, and Antibiotics.
Medicines for treating allergies are manufactured and exported.
Anti-inflammatory drugs are produced for pain and inflammation.
Antibacterial drugs are developed to combat various infections.
Board of directors of Mps Pharmaa Limited (MPS Pharmaa Limited)
Mps Pharmaa Limited is the primary company behind MPS Pharmaa Limited. The board of Mps Pharmaa Limited currently have 4 directors; the longest-serving is Peeyush Kumar Aggarwal, appointed in 2013. 23 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Peeyush Kumar Aggarwal DIN 00090423 | Managing Director | 31 Jul 2013 | 13 yrs 2 mo | Mps Pharmaa Limited |
| Madhu Sharma DIN 06947852 | Director | 31 Jan 2017 | 9 yrs 8 mo | Mps Pharmaa Limited |
| Ram Niwas Sharma DIN 08427985 | Director | 23 Aug 2019 | 7 yrs 1 mo | Mps Pharmaa Limited |
| Ajay Sharma DIN 03344008 | Director | 13 Jul 2023 | 3 yrs 3 mo | Mps Pharmaa Limited |
People of MPS Pharmaa Limited
1 people are tracked at MPS Pharmaa Limited (1 in leadership).
| Name | Role | Group |
|---|---|---|
Rajeev Awasthi | CEO | Leadership |
Complete people profiles for MPS Pharmaa Limited
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of MPS Pharmaa Limited
Figures of Mps Pharmaa Limited, the primary company behind MPS Pharmaa Limited, for FY 2025. Revenue was ₹4.8 Lakh (-49% year on year). Net loss was -₹89.8 Lakh (-1882% margin). EBITDA was -₹71.7 Lakh (-1502% margin). Revenue has grown at a compounded annual rate of -45% over three years and +26% over five years.
- ₹4.8 LakhRevenue · FY 2025 · -49% YoY
- -₹89.8 LakhNet loss · -1882% margin
- -₹71.7 LakhEBITDA · -1502% margin
- ₹19.11 CrPaid-up capital
- 13Employees (provident fund records)
- -45%Revenue CAGR, 3 years
- +26%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Mps Pharmaa Limited are on its company page.
Detailed financial statements for MPS Pharmaa Limited
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Top companies in Traditional Health & Nutrition
10 companies that operate in the same segment as MPS Pharmaa Limited (Traditional Health & Nutrition), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Manufacturer of generics formulations | 2002 | Bridgewater, New Jersey, United States | – | USD 3.02 B | 8,300 | |
Biosimilar therapeutics are developed for oncology and autoimmune diseases. | 2010 | Redwood City, California, United States | USD 143.62 M | USD 42.17 M | 228 | |
Oral solid drug delivery systems are manufactured and developed. | 1985 | Mumbai, Maharashtra, India | USD 42.49 M | USD 89.42 M | 962 | |
Ophthalmic pharmaceuticals and instruments are developed for eye care. | 1853 | Bridgewater, New Jersey, United States | – | USD 5.1 B | 13,500 | |
Generic pharmaceuticals are manufactured by Teva Pharmaceuticals. | 1901 | Petah Tikva, Central District, Israel | USD 500 M | USD 18.74 B | 51,792 | |
Generic, semi-solid, and liquid dosage forms are manufactured. | 1990 | Bengaluru, Karnataka, India | – | USD 508.93 M | 5,180 | |
Pharmaceutical products are developed and marketed globally. | 2009 | Montville, New Jersey, United States | USD 155.92 M | – | – | |
Specialty generic pharmaceuticals and APIs are manufactured and marketed. | 1983 | Mumbai, Maharashtra, India | – | USD 6.21 B | 25,870 | |
Pharmaceutical company engaged in developing, manufacturing, and marketing a diverse range of pharmaceutical formulations | 1991 | Delhi, Delhi, India | USD 367.2 M | USD 1.52 B | 21,320 | |
Generics, biosimilars, APIs, and vaccines are manufactured by Wockhardt. | 1967 | Mumbai, Maharashtra, India | – | USD 353.53 M | 3,410 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Mps Pharmaa Limited
Complete news archive for MPS Pharmaa Limited
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about MPS Pharmaa Limited
MPS Pharmaa Limited was founded in 1997.
MPS Pharmaa Limited is headquartered in Delhi, India. It is registered at Delhi, Delhi, India.
Rajeev Awasthi is the current CEO of MPS Pharmaa Limited.
The primary company behind MPS Pharmaa Limited, Mps Pharmaa Limited, reported revenue of ₹4.8 Lakh for FY 2025, down 49% year on year.
MPS Pharmaa Limited, formerly known as Advik Laboratories Limited, is involved in the manufacturing and exporting of a wide range of pharmaceutical medicines. Products include anti-allergic capsules and tablets, anti-inflammatory drugs, antihypertensives, analgesics, antipyretics, and antibiotics. The company operates with WHO and GMP certifications, aiming for USFDA quality standards. It serves both Indian and global markets, maintaining leadership in product quality, competitive pricing, and customer service. The business is supported by a team of qualified professionals dedicated to producing high-quality medicines for various therapeutic needs.
MPS Pharmaa Limited offers Anti-Allergic Medicines, Anti-Inflammatory Medicines, and Antibiotics.
MPS Pharmaa Limited operates through Mps Pharmaa Limited.
The legal entities of MPS Pharmaa Limited currently have 6 directors, including Ram Niwas Sharma, Peeyush Kumar Aggarwal, Pooja Chuni and others.